“Phase II trial of romidepsin (FK228 or depsipeptide) in peripheral T-cell lymphoma: clinical activity and molecular markers”, Hematol Meeting Rep, vol. 2, no. 13, Jun. 2009, doi: 10.4081/hmr.v2i13.482.